diversity and inclusion

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

R&D

EDI in clinical research: The case for adaptive strategies a...

The topic of Equality, Diversity, and Inclusion (EDI) in health and care research participation has been gaining traction in the past few years.

R&D

Making accessibility strategy part of your rare disease tria...

Over the past several years, diversity, equity, and inclusion (DEI) has become a central subject of conversation in clinical trials.

Patients

Tech to make healthcare more accessible for Latinx patients

How emerging technology could make healthcare more accessible for Spanish-speaking communities.

News

Digital monitoring could be a leveller in diabetes therapy

A digital tool developed by DarioHealth has been shown to help patients with type 2 diabetes manage their blood sugar more effectively, regardless of their demographic background, in a new

News

Bayer tops pharma rankings for diversity, inclusivity

The largest pharma companies have all set themselves ambitious targets in recent years to improve representation for women and minority communities in their businesses, but are they meeting

R&D

Can technology help diversify clinical trials?

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials.